Investing.comQwen · 实盘不做把握 3/10不做原因:无可交易标的
北京时间·🕒 发布 20:04:32·⟳ 抓取 20:05:12 +40s·⚡ 决策 08-28 20:35:47 +30m35s·60.0 天前
ENvue Medical宣布1:12缩股，9月1日生效，旨在维持纳斯达克上市地位
反向股票分割是程序性公司行动，不改变股东权益比例和公司基本面，无方向性交易edge；且该标的为微盘股（缩股后仅约92万股流通），流动性极差，无法形成可执行的正期望交易。
📄 原文Investing.com↗ 原文
ENvue Medical announces 1-for-12 reverse stock split
Warsh, Nvidia And oil In focus - what’s moving markets TYLER, Texas - ENvue Medical, Inc. (NASDAQ:FEED) announced a 1-f…
不做 ENvue Medical（FEED.US）
反向股票分割为维持上市合规的程序性动作，不改变股东权益比例和公司基本面，无方向性交易edge；缩股后流通盘仅约92万股，流动性极差，无法形成可执行的正期望交易。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
ENvue Medical宣布1:12缩股以维持纳斯达克最低股价要求，9月1日生效。缩股不改变股东持股比例和公司价值，属于合规性程序动作。历史上微盘股缩股后短期波动加大但无系统性方向，且该标的流通盘极小（缩股后约92万股），流动性不足以支撑有意义的方向性交易。结论：不做。
🔎 新鲜度:最早出现 2026-08-28 · 扩散 low · price-in 风险 low ↗
主要风险
- 缩股后流通盘极小（约92万股），买卖价差大、流动性极差，任何方向性交易都面临严重执行风险
先例如何影响了这次决策
对本次决策的影响:先例不足不改变结论：缩股本身无方向性edge，程序性动作不构成交易催化
方向:无可用先例
涨幅量级:无
形态:无
原文全文
展开原文 · 2,051 字
Warsh, Nvidia And oil In focus - what’s moving markets
TYLER, Texas - ENvue Medical, Inc. (NASDAQ:FEED) announced a 1-for-12 reverse stock split of its common stock expected to become effective on September 1, 2026, according to a press release statement.
The company’s common stock will begin trading on the Nasdaq Capital Market on a post-split basis at the market open on Monday under the existing trading symbol "FEED" with a new CUSIP number, 63008J876.
Following the reverse stock split, every twelve shares of common stock will be combined into one share. The company’s outstanding common stock will be reduced from 11,084,616 shares to approximately 923,718 shares. The company’s authorized shares remain unchanged at 40,000,000 shares of common stock.
No fractional shares will be issued, as any fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share on a per stockholder basis.
The reverse stock split was approved by the company’s board of directors under authority granted by stockholders at a special meeting held on August 14, 2026.
The reverse stock split will not affect any stockholder’s percentage ownership of the company or voting power, except for minimal effects from the treatment of fractional shares. All options, convertible securities including preferred stock, restricted stock, restricted stock units and warrants outstanding prior to the reverse stock split will be adjusted accordingly.
The number of authorized shares of preferred stock and the par value of the common stock or preferred stock will remain unchanged. Shares of the company’s common stock will maintain the same proportional voting rights and rights to dividends and distributions after the reverse stock split.
VStock Transfer, LLC will act as the exchange agent for the reverse stock split.
ENvue Medical is a commercial-stage medical technology company specializing in enteral care solutions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
TYLER, Texas - ENvue Medical, Inc. (NASDAQ:FEED) announced a 1-for-12 reverse stock split of its common stock expected to become effective on September 1, 2026, according to a press release statement.
The company’s common stock will begin trading on the Nasdaq Capital Market on a post-split basis at the market open on Monday under the existing trading symbol "FEED" with a new CUSIP number, 63008J876.
Following the reverse stock split, every twelve shares of common stock will be combined into one share. The company’s outstanding common stock will be reduced from 11,084,616 shares to approximately 923,718 shares. The company’s authorized shares remain unchanged at 40,000,000 shares of common stock.
No fractional shares will be issued, as any fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share on a per stockholder basis.
The reverse stock split was approved by the company’s board of directors under authority granted by stockholders at a special meeting held on August 14, 2026.
The reverse stock split will not affect any stockholder’s percentage ownership of the company or voting power, except for minimal effects from the treatment of fractional shares. All options, convertible securities including preferred stock, restricted stock, restricted stock units and warrants outstanding prior to the reverse stock split will be adjusted accordingly.
The number of authorized shares of preferred stock and the par value of the common stock or preferred stock will remain unchanged. Shares of the company’s common stock will maintain the same proportional voting rights and rights to dividends and distributions after the reverse stock split.
VStock Transfer, LLC will act as the exchange agent for the reverse stock split.
ENvue Medical is a commercial-stage medical technology company specializing in enteral care solutions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。